Tag: WRAPSODY WAVE
Renal Interventions’ top 10 stories of September 2024
September brought with it six-month trial outcomes, funding updates, and all-time lows, with Merit Medical presenting six-month results from the Wrapsody WAVE trial, Venova...
Merit Medical’s Wrapsody WAVE trial demonstrates superior patency versus standard of...
Merit Medical has today announced positive six-month findings from the randomised arteriovenous (AV) fistula arm of its Wrapsody Arteriovenous Access Efficacy (WAVE) pivotal trial....
“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...
Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...